Home » Thermo Fisher, Cynvenio Ink Distribution Agreement for LiquidBiopsy Platform

Thermo Fisher, Cynvenio Ink Distribution Agreement for LiquidBiopsy Platform

Jan 13, 2015
|
staff reporter

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Cynvenio Biosystems have signed a distribution agreement for Cynvenio's LiquidBiopsy platform, the companies said today.

Cynvenio's LiquidBiopsy platform is designed to extract and isolate circulating tumor cells from a blood draw and prepare them for imaging and genomic analysis. According to Cynvenio's website, the platform uses a patented microfluidic chip to recover tumor cells from whole blood and can process up to four samples in under three hours.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

What's Popular?

In Business News

  1. Illumina Settles One Patent Dispute With Qiagen; Faces Separate Suit From Columbia, Qiagen

  2. Illumina Selects Five More Startups for Accelerator Program

  3. Thermo Fisher Scientific Q2 Revenues Up 10 Percent; Firm Increases 2017 Guidance Again

  4. UPDATE: CRISPR Stakeholders Seek Reversal of Patent Interference Proceeding Decision

  5. Exact Sciences Q2 Revenues Up 172 Percent

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.